0001567619-19-009487.txt : 20190430
0001567619-19-009487.hdr.sgml : 20190430
20190430175139
ACCESSION NUMBER: 0001567619-19-009487
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190411
FILED AS OF DATE: 20190430
DATE AS OF CHANGE: 20190430
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUBOW JORDAN
CENTRAL INDEX KEY: 0001775155
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 19783794
MAIL ADDRESS:
STREET 1: 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
doc1.xml
FORM 4
X0306
4
2019-04-11
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001775155
DUBOW JORDAN
BLOCK 10-1, BLANCHARDSTOWN
CORPORATE PARK, BALLYCOOLIN
DUBLIN
L2
15
IRELAND
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
1.44
2019-04-11
4
A
0
340000
1.44
A
2029-04-11
ADSs
340000
340000
D
Options become exercisable as to 85,000 ADSs on each of the first four anniversaries after the 04/11/2019 grant date.
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
Remarks to Table I: No non-derivative securities are beneficially owned.
/s/ Phillandas T. Thompson as attorney-in-fact for Jordan Dubow, M.D.
2019-04-30